Business Update
Clinical Data and Lab21 launch cardiac channelopathy genetic test in United Kingdom and Ireland
Published in Cardiovascular Business Week, January 9th, 2007
Under terms of this agreement, Lab21 will have exclusive rights in the U.K. and Ireland to market and sell Clinical Data's Familion test, a genetic test designed to identify mutations in people with inherited cardiac channelopathies such as Long QT Syndrome (LQTS) and Brugada Syndrome. In addition, the parties have agreed to consider other proprietary, molecular and pharmacogenomic tests developed and commercialized by PGxHealth for future launch in the U.K. and Ireland.
John Schultz,...
Want to see the full article?
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Cardiovascular Business Week
More Articles from Cardiovascular Business Week
- Aneurysms
Thirty-fifth patient enrolled in NeuroVasx cPAX aneurysm treatment system clinical study - Angiology
Nonsurgical treatment available for arteriovenous malformations - Angiology
Studies from Hamad Medical Corporation add new findings in the area of angiology - Atrial Fibrillation
CryoCath provides 12-month update on pivotal atrial fibrillation study - Biomedical Engineering
University of Michigan researchers develop new approach to growing heart muscle - Business Update
Chugai Pharmaceutical concludes co-promotion agreement for Pletaal - More from this issue of Cardiovascular Business Week
NewsRx is Social
Follow us on your favorite social network by clicking on a button below:
Top Medical Newsletters
Awards
Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005
Facts & Stats
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.
- Google 2010 PageRank: #2 Among Top Health News and Media Publications
- Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
- Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
- Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry
